Drug Infusion Systems Market Developments and Growth Opportunities Across 2026–2030

Global Drug Infusion Systems Market

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Drug Infusion Systems Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The drug infusion systems market size has experienced strong growth in recent years. It is projected to expand from $14.23 billion in 2025 to $15.51 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.0%. This historical increase can be attributed to factors such as increasing hospitalization rates, the rising prevalence of chronic diseases, the expansion of oncology and chemotherapy treatments, the growing use of intravenous drug delivery, and improved availability of infusion technologies.

The market for drug infusion systems is projected to experience substantial expansion over the upcoming years. It is set to reach $22.23 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 9.4%. This anticipated growth during the prediction period can be ascribed to several factors, including the increasing use of connected infusion systems, a heightened demand for ambulatory and homecare infusion solutions, the broadening of precision drug delivery methods, an intensified emphasis on workflow automation within hospitals, and increased financial commitments to intelligent healthcare infrastructure. Key developments expected during this timeframe encompass the growing implementation of smart infusion pumps, a greater incorporation of dose error reduction systems, an expanding utilization of multi-channel infusion devices, the wider availability of home-based infusion therapies, and a stronger emphasis on characteristics that promote patient safety.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10703&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Drug Infusion Systems Market?

Increasing spending on healthcare is anticipated to fuel expansion in the drug infusion systems market in the future. Healthcare expenditure represents the cumulative funds allocated to healthcare products and services within a specified timeframe, usually an annual period. A rise in healthcare spending equips hospitals, clinics, and other healthcare facilities with greater financial capacity to invest in sophisticated drug infusion systems, consequently boosting the demand for these products. For example, reports released by the UK’s Office for National Statistics (ONS) in May 2024 indicated that overall healthcare expenditure saw a nominal increase of 5.6% between 2022 and 2023, significantly higher than the 0.9% growth recorded in 2022. Consequently, the expansion of healthcare expenditure is projected to stimulate the growth of the drug infusion systems market.

What Major Segment Divisions Exist Within The Drug Infusion Systems Market?

The drug infusion systems market covered in this report is segmented –

1) By Product Type: Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, Insulin Pump, Implantable Infusion System

2) By Route Of Administration: Intravenous, Subcutaneous, Arterial, Epidural, Other Routes Of Administration

3) By Application: Oncology And Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, Other Applications

4) By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other End Users

Subsegments:

1) By Elastomeric Infusion System: Non-Vented Elastomeric Pumps, Vented Elastomeric Pumps

2) By Disposable Infusion System: Disposable Infusion Pumps, IV Sets With Disposable Components

3) By Syringe Infusion System: Manual Syringe Infusion Pumps, Electric Syringe Infusion Pumps

4) By Peristaltic Pump: Single-Channel Peristaltic Pumps, Multi-Channel Peristaltic Pumps

5) By Multi-Channel Pump: Multi-Channel Infusion Pumps For General Use, Multi-Channel Pumps For Specific Therapies

6) By Patient-Controlled Analgesia (PCA) Pump: Electronic PCA Pumps, Mechanical PCA Pumps

7) By Insulin Pump: Continuous Subcutaneous Insulin Infusion (CSII) Pumps, Patch Insulin Pumps

8) By Implantable Infusion System: Implantable Pumps For Chronic Pain, Implantable Pumps For Chemotherapy

How Are Trends Shaping The Direction Of The Drug Infusion Systems Market?

Major companies operating in the drug infusion systems market are developing advanced technologies, such as cloud-based infusion management systems, to improve patient care, enhance accuracy, and streamline the management of infusion therapies. Cloud-based infusion management systems serve as digital platforms that facilitate the monitoring, administration, and tracking of medication infusions through the cloud. For instance, in June 2023, Eitan Medical, a US-based global leader in advanced infusion therapy and drug delivery solutions, launched Eitan Insights, a new cloud-based infusion management system tailored to meet the specific needs of home and specialty infusions. Eitan Insights is designed to provide healthcare professionals with real-time data and analytics, empowering them to monitor patients remotely and modify treatment plans as necessary. This system enhances medication safety by minimizing the risk of errors and improving adherence to prescribed protocols.

Which Companies Are Leading Innovation In The Drug Infusion Systems Market?

Major companies operating in the drug infusion systems market are Medtronic plc, Baxter International Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Smiths Group plc, Terumo Corporation, Fresenius SE & Co. KGaA, ICU Medical Inc., Tandem Diabetes Care Inc., Insulet Corporation, Ypsomed Holding AG, Abbott Diabetes Care Inc., Flowonix Medical Inc., Zyno Medical Inc., IRadimed Corporation, Debiotech S.A., Valeritas Inc., Disetronic Medical Systems AG, Alaris Health Systems Inc., Hospira Inc., Mindray Medical International Limited

Read the full drug infusion systems market report here:

https://www.thebusinessresearchcompany.com/report/drug-infusion-systems-global-market-report

What Are The Leading Geographic Regions In The Drug Infusion Systems Market?

North America was the largest region in the drug infusion systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in the drug infusion systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Drug Infusion Systems Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10703&type=smp

Browse Through More Reports Similar to the Global Drug Infusion Systems Market 2026, By The Business Research Company

Infusion Pump Market Report 2026

https://www.thebusinessresearchcompany.com/report/infusion-pump-global-market-report

Intravenous Infusion Pumps Market Report 2026

https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report

Perfusion Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/perfusion-systems-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model